register

News & Trends - MedTech & Diagnostics

World’s smallest imaging device to benefit patients with heart disease

Health Industry Hub | July 22, 2020 |

MedTech News: An international team of researchers and engineers has developed the world’s tiniest device set to change the way we see human diseases.

A new study, published in the prestigious journal Light: Science & Applications, outlines how the team developed the world’s tiniest endoscope.

Lead author Dr Jiawen Li is an associate investigator and Heart Foundation Postdoctoral Fellow at the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP) at the University of Adelaide. She says, ultimately, the endoscope will help clinicians better understand the causes and progression of various diseases.

At the heart of the endoscope is a tiny 3D printed lens on the end of an optical fibre, as thin as a single human hair. With a protective catheter sheath, the entire device is less than half a millimetre wide. This means it can safely fit inside a narrow artery.

‘We used the technology to take 3D scans of atherosclerotic plaques inside blood vessel walls,’ Dr Li said. ‘These are a common cause of heart attacks.’

The images Dr Li and the team received were of a higher quality than what is possible from the fibre-optic tools currently used for preclinical and clinical cardiovascular disease diagnostics. And because the tool is so small, it’s less likely to cause any damage to the body.

While smaller endoscopes were always necessary for these diagnostics, the problem previously was how to make a smaller lens. It was next to impossible to create a hair-sized device with all the complicated optics inside, so the team turned to 3D microprinting.

‘To shrink it using traditional manufacturing methods caused a lot of problems with the blurring of images. They weren’t high quality,’ Dr Li said. ‘What’s nice with 3D microprinting is you can print whatever shape you want on such a tiny scale.’

Within the team are world leaders in 3D printing from the University of Stuttgart. They worked with Dr Li to print complicated lenses only a few hundred microns in diameter. The end result is not only a tiny endoscope but one that captures clear, sharp images.

In Australia 157 people are hospitalised every day due to heart attacks. Around one in 10 of these people are likely to be readmitted for a second one within a year. The endoscope can help detect and prevent these secondary heart attacks by assessing plaque in the arteries after the initial attack.

The CNBP team of engineers, physicists, cardiologists and biologists also hope the technology can help a wider range of patients by detecting other conditions such as lung cancer.

‘The endoscope can fit into the small branches of airways without causing damage,’ Dr Li said.

It could also help develop better drugs and treatments, or guide stents into arteries.

The next steps to move the tool past a proof of concept are further studies and to closely examine how diseases progress.

‘We want to give people the opportunity to receive the best treatment by helping doctors to see the disease more clearly,’ Dr Li said. ‘The technology could help save a patient’s life.’


News & Trends - MedTech & Diagnostics

APAC medtech company scores TGA approval in heart disease

APAC medtech company scores TGA approval in heart disease

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics News: An Asia Pacific medtech company has announced that its flagship drug-eluting stent (DES) has received regulatory […]

More


News & Trends - MedTech & Diagnostics

New state-based pilot to back home-grown medtech innovation

New state-based pilot to back home-grown medtech innovation

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics: In a bid to enhance opportunities for local medtech manufacturers to sell to health services, a connected […]

More


News & Trends - Pharmaceuticals

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Health Industry Hub | October 4, 2024 |

Pharma News: Ferring Pharmaceuticals has announced results from a new study, which provides the first real-world evidence supporting the efficacy […]

More


News & Trends - Pharmaceuticals

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Health Industry Hub | October 4, 2024 |

Pharma News: Australian women are calling for more accurate information about their contraceptive options, with 70% feeling inadequately educated about […]

More


This content is copyright protected. Please subscribe to gain access.